Drug
Who makes lomitapide mesylate?
2 companies list lomitapide mesylate as a human prescription drug, including under the names Juxtapid. Forms: capsule. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing lomitapide mesylate
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Chiesi USA, Inc.Italy | capsule | NDANDA203858 | 5 | 1 |
| Amryt Pharmaceuticals DAC | capsule | NDANDA203858 | 2 | 0 |
Bulk ingredient listings
- Alivus Life Sciences Limited · 1 NDC
- Maithri Drugs Private LimitedIndia · 1 NDC
- PPL Pharma Solutions Riverview LLCUnited States · 1 NDC
Orange Book patents
2 unexpired patents list lomitapide mesylate as the active ingredient, expiring between Aug 2027 and Jul 2041. Application holder: CHIESI FARMACEUTICI SPA.
Enquiry
Common questions
- Who makes lomitapide mesylate?
- 2 companies list lomitapide mesylate as a human prescription drug in the openFDA NDC Directory, led by Chiesi USA, Inc., Amryt Pharmaceuticals DAC. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Who supplies lomitapide mesylate active ingredient?
- 3 companies list lomitapide mesylate as a bulk ingredient, including Alivus Life Sciences Limited, Maithri Drugs Private Limited, PPL Pharma Solutions Riverview LLC.